Searched for
EMA SCIENTIFIC COMMITTEE
ET 40 under forty: The vanguard leading India into the futureThe ET 40 Under Forty list for 2025 celebrates innovative leaders across India, including pioneers in spacetech, AI, and blockchain. For th...- Biocon Biologics' biosimilar human insulin gets backing from EMA expert panelThe EMA's Committee for Medicinal Products for Human Use (CHMP) opinion will be considered by the European Commission. "The European Commis...
- Welcome, t(w)eens, to Covid vaccinesAs India inoculates more of its population, it must not forget large sections of the global population who are yet to receive their first o...
- How worried should we be about links of blood clots to AstraZeneca's vaccine?The EMA said its vaccine side effects monitoring system, as of April 4, had received 169 reports of cases of cerebral venous sinus thrombos...
- EU countries to resume AstraZeneca jabs after 'safe' verdictThe closely-watched announcement from the European Medicines Agency (EMA) came after the WHO and Britain's health watchdog both said the va...
- EU drug agency discounts any link between AstraZeneca covid vaccine and clotsThe head of the EMA, Emer Cooke said Thursday that the agency "cannot rule out definitively a link" between rare types of blood clots and t...
- Key questions as EU watchdog rules on AstraZenecaThe EMA is the regulator for all human and animal medicines in the 27 nations of the European Union plus the European Economic Area countri...
- EU regulator approves Pfizer-BioNTech vaccineThe Amsterdam-based regulator dramatically moved the decision on the jab ahead from December 29, following pressure to accelerate the proce...
- How the world has sped up vaccine approvalsAs authorities in the US and Europe probe other candidates, here is how countries have sped up their approval procedures to face up to the ...
- Lupin gets European Commission nod for myotonia treatment drugLupin said it is preparing for the launch of NaMuscla, which will occur in the initial markets of Germany and the UK in the first quarter o...
- EU hoping for solution after FTA talks stalled over drug banEU defended its decision to ban around 700 generic drugs clinically tested by GVK Biosciences which had prompted India to defer the talks o...
- India may contest EU move to ban 700 drugsIndia may contest a decision by the European drug regulator to recommend a ban on as many as 700 generic products tested by GVK Biosciences
- Tatas, L&T and Infosys: How to choose their next leader?The six key questions that companies must ask and answer if they want to choose right.
Load More
